Healthcare & Pharmaceuticals
Actavis, the world's third-largest generic drug manufacturer, has been sued by New York state to prevent it from forcing patients to take a new version of a popular Alzheimer's drug. The company is attempting to hook patients on an extended release version before its U.S. patent expires next year.
A Congressional investigation of the money that drug companies give as supposed educational grants has found that the payments are growing rapidly and are sometimes steered by marketing executives to doctors and groups who push unapproved uses of drugs.
Over the last two years, thousands of people have gathered to counter the annual conventions of the biotechnology industry in Boston and San Diego. This year, people will be converging on Toronto to broaden the biojustice movement and challenge the biotechnology industry and their vision for our future. It will be a gathering to learn, strategize and network about genetic engineering in agriculture and pharmaceuticals, biowarfare, genetic and non-genetic discrimination, trade regimes and corporate control, patenting of life and more. This event is timed to challenge the industry's annual convention BIO2002, Toronto, June 9-12.
Three major U.S. medical associations - the American Academy of Family Physicians, the American Academy of Pediatrics and the American College of Cardiology - have bowed to pressure from activist doctors to stop accepting corporate donations from Coca-Cola. The campaigners say Coke exerted undue influence over the medical groups.
Hospital Corporation of America (HCA) - the world's largest operator of private clinics and hospitals - has come under the spotlight for performing unnecessary cardiac procedures, notably in Florida.
GlaxoSmithKline is to discount significantly its pneumonia vaccine for private customers in Africa after claims from a medical charity it is "profiteering" by charging western prices.
US officials have refused to bust Bayer's monopoly on anthrax drugs, even though generic drugs would save $millions. Bayer's patent was protected under the WTO. Now those rights are challenged.
Many veterans' advocates believe a certain anthrax vaccine to be a major cause of Gulf War sickness. The company manufacturing it has launched a massive lobbying campaign to persuade the Bush administration to stockpile the controversial drug so it can be administered to civilians.
African leaders used the opening of the UN General Assembly Special Session on HIV-AIDS Monday to assail the international community's response to the deadly epidemic for failing to match the speed and seriousness with which the disease is infecting their citizens. Official after official rose to drive home the message that the death of more than 20 million people, mostly in sub-Saharan Africa, demands that more money be committed to the fight.